SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
IKZF2
|
ENSG00000030419.12 | IKAROS family zinc finger 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
IKZF2 | hg19_v2_chr2_-_214016314_214016343 | 0.97 | 5.5e-13 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_-_28125638 | 6.66 |
ENST00000545234.1
|
PTHLH
|
parathyroid hormone-like hormone |
chr1_+_158979686 | 4.49 |
ENST00000368132.3
ENST00000295809.7 |
IFI16
|
interferon, gamma-inducible protein 16 |
chr1_+_158979680 | 4.43 |
ENST00000368131.4
ENST00000340979.6 |
IFI16
|
interferon, gamma-inducible protein 16 |
chr16_+_82660560 | 4.40 |
ENST00000268613.10
ENST00000565636.1 ENST00000431540.3 ENST00000428848.3 |
CDH13
|
cadherin 13 |
chr12_-_52867569 | 4.32 |
ENST00000252250.6
|
KRT6C
|
keratin 6C |
chr19_-_42947121 | 4.09 |
ENST00000601181.1
|
CXCL17
|
chemokine (C-X-C motif) ligand 17 |
chr17_-_39093672 | 3.82 |
ENST00000209718.3
ENST00000436344.3 ENST00000485751.1 |
KRT23
|
keratin 23 (histone deacetylase inducible) |
chr2_-_214014959 | 3.81 |
ENST00000442445.1
ENST00000457361.1 ENST00000342002.2 |
IKZF2
|
IKAROS family zinc finger 2 (Helios) |
chr12_-_50677255 | 3.74 |
ENST00000551691.1
ENST00000394943.3 ENST00000341247.4 |
LIMA1
|
LIM domain and actin binding 1 |
chr11_+_58938903 | 3.65 |
ENST00000532982.1
|
DTX4
|
deltex homolog 4 (Drosophila) |
chr1_+_158979792 | 3.60 |
ENST00000359709.3
ENST00000430894.2 |
IFI16
|
interferon, gamma-inducible protein 16 |
chr6_+_144665237 | 3.58 |
ENST00000421035.2
|
UTRN
|
utrophin |
chr13_-_38172863 | 3.58 |
ENST00000541481.1
ENST00000379743.4 ENST00000379742.4 ENST00000379749.4 ENST00000541179.1 ENST00000379747.4 |
POSTN
|
periostin, osteoblast specific factor |
chr21_-_28215332 | 3.32 |
ENST00000517777.1
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
chr6_+_106988986 | 3.20 |
ENST00000457437.1
ENST00000535438.1 |
AIM1
|
absent in melanoma 1 |
chr2_-_237416071 | 3.01 |
ENST00000309507.5
ENST00000431676.2 |
IQCA1
|
IQ motif containing with AAA domain 1 |
chr2_+_158114051 | 2.97 |
ENST00000259056.4
|
GALNT5
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 5 (GalNAc-T5) |
chr7_-_127672146 | 2.92 |
ENST00000476782.1
|
LRRC4
|
leucine rich repeat containing 4 |
chr10_-_98031265 | 2.80 |
ENST00000224337.5
ENST00000371176.2 |
BLNK
|
B-cell linker |
chr5_-_42811986 | 2.79 |
ENST00000511224.1
ENST00000507920.1 ENST00000510965.1 |
SEPP1
|
selenoprotein P, plasma, 1 |
chr14_-_36988882 | 2.74 |
ENST00000498187.2
|
NKX2-1
|
NK2 homeobox 1 |
chr4_+_26322409 | 2.74 |
ENST00000514807.1
ENST00000348160.4 ENST00000509158.1 ENST00000355476.3 |
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region |
chr15_+_43885252 | 2.66 |
ENST00000453782.1
ENST00000300283.6 ENST00000437924.1 ENST00000450086.2 |
CKMT1B
|
creatine kinase, mitochondrial 1B |
chr1_+_68150744 | 2.54 |
ENST00000370986.4
ENST00000370985.3 |
GADD45A
|
growth arrest and DNA-damage-inducible, alpha |
chr15_+_43985084 | 2.51 |
ENST00000434505.1
ENST00000411750.1 |
CKMT1A
|
creatine kinase, mitochondrial 1A |
chr15_+_43985725 | 2.46 |
ENST00000413453.2
|
CKMT1A
|
creatine kinase, mitochondrial 1A |
chr2_-_237416181 | 2.42 |
ENST00000409907.3
|
IQCA1
|
IQ motif containing with AAA domain 1 |
chr6_-_31846744 | 2.42 |
ENST00000414427.1
ENST00000229729.6 ENST00000375562.4 |
SLC44A4
|
solute carrier family 44, member 4 |
chr9_+_132099158 | 2.41 |
ENST00000444125.1
|
RP11-65J3.1
|
RP11-65J3.1 |
chr13_+_73629107 | 2.40 |
ENST00000539231.1
|
KLF5
|
Kruppel-like factor 5 (intestinal) |
chr1_+_79115503 | 2.39 |
ENST00000370747.4
ENST00000438486.1 ENST00000545124.1 |
IFI44
|
interferon-induced protein 44 |
chr4_-_83765613 | 2.38 |
ENST00000503937.1
|
SEC31A
|
SEC31 homolog A (S. cerevisiae) |
chr3_+_118905564 | 2.37 |
ENST00000460625.1
|
UPK1B
|
uroplakin 1B |
chr10_-_98031310 | 2.36 |
ENST00000427367.2
ENST00000413476.2 |
BLNK
|
B-cell linker |
chr2_-_216240386 | 2.33 |
ENST00000438981.1
|
FN1
|
fibronectin 1 |
chr3_-_18480260 | 2.33 |
ENST00000454909.2
|
SATB1
|
SATB homeobox 1 |
chr5_-_42812143 | 2.33 |
ENST00000514985.1
|
SEPP1
|
selenoprotein P, plasma, 1 |
chrX_+_100805496 | 2.32 |
ENST00000372829.3
|
ARMCX1
|
armadillo repeat containing, X-linked 1 |
chr20_-_45981138 | 2.24 |
ENST00000446994.2
|
ZMYND8
|
zinc finger, MYND-type containing 8 |
chr6_-_75912508 | 2.23 |
ENST00000416123.2
|
COL12A1
|
collagen, type XII, alpha 1 |
chr4_-_74486217 | 2.20 |
ENST00000335049.5
ENST00000307439.5 |
RASSF6
|
Ras association (RalGDS/AF-6) domain family member 6 |
chr3_+_171844762 | 2.17 |
ENST00000443501.1
|
FNDC3B
|
fibronectin type III domain containing 3B |
chr11_-_8892464 | 2.17 |
ENST00000527347.1
ENST00000526241.1 ENST00000526126.1 ENST00000530938.1 ENST00000526057.1 |
ST5
|
suppression of tumorigenicity 5 |
chr9_+_34989638 | 2.16 |
ENST00000453597.3
ENST00000335998.3 ENST00000312316.5 |
DNAJB5
|
DnaJ (Hsp40) homolog, subfamily B, member 5 |
chrX_-_43741594 | 2.15 |
ENST00000536181.1
ENST00000378069.4 |
MAOB
|
monoamine oxidase B |
chr1_+_117963209 | 2.14 |
ENST00000449370.2
|
MAN1A2
|
mannosidase, alpha, class 1A, member 2 |
chr1_+_24646002 | 2.12 |
ENST00000356046.2
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
chr12_-_26278030 | 2.09 |
ENST00000242728.4
|
BHLHE41
|
basic helix-loop-helix family, member e41 |
chr3_-_18466026 | 2.08 |
ENST00000417717.2
|
SATB1
|
SATB homeobox 1 |
chr1_+_24645865 | 2.06 |
ENST00000342072.4
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
chr2_-_230787879 | 2.03 |
ENST00000435716.1
|
TRIP12
|
thyroid hormone receptor interactor 12 |
chr15_+_96876340 | 2.00 |
ENST00000453270.2
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
chr1_+_24645807 | 1.97 |
ENST00000361548.4
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
chr3_+_156393349 | 1.97 |
ENST00000473702.1
|
TIPARP
|
TCDD-inducible poly(ADP-ribose) polymerase |
chr7_-_135194822 | 1.92 |
ENST00000428680.2
ENST00000315544.5 ENST00000423368.2 ENST00000451834.1 ENST00000361528.4 ENST00000356162.4 ENST00000541284.1 |
CNOT4
|
CCR4-NOT transcription complex, subunit 4 |
chr1_+_100111580 | 1.89 |
ENST00000605497.1
|
PALMD
|
palmdelphin |
chr4_-_74486347 | 1.84 |
ENST00000342081.3
|
RASSF6
|
Ras association (RalGDS/AF-6) domain family member 6 |
chr21_+_39628852 | 1.83 |
ENST00000398938.2
|
KCNJ15
|
potassium inwardly-rectifying channel, subfamily J, member 15 |
chr17_+_7387677 | 1.83 |
ENST00000322644.6
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa |
chr18_+_12288288 | 1.82 |
ENST00000586226.1
|
RP11-64C12.8
|
RP11-64C12.8 |
chr15_+_43885799 | 1.77 |
ENST00000449946.1
ENST00000417289.1 |
CKMT1B
|
creatine kinase, mitochondrial 1B |
chr1_-_161337662 | 1.77 |
ENST00000367974.1
|
C1orf192
|
chromosome 1 open reading frame 192 |
chr6_+_116691001 | 1.75 |
ENST00000537543.1
|
DSE
|
dermatan sulfate epimerase |
chr1_+_24645915 | 1.75 |
ENST00000350501.5
|
GRHL3
|
grainyhead-like 3 (Drosophila) |
chr6_-_128841503 | 1.74 |
ENST00000368215.3
ENST00000532331.1 ENST00000368213.5 ENST00000368207.3 ENST00000525459.1 ENST00000368210.3 ENST00000368226.4 ENST00000368227.3 |
PTPRK
|
protein tyrosine phosphatase, receptor type, K |
chr12_+_15154767 | 1.73 |
ENST00000542689.1
|
RP11-508P1.2
|
RP11-508P1.2 |
chr15_+_73976545 | 1.73 |
ENST00000318443.5
ENST00000537340.2 ENST00000318424.5 |
CD276
|
CD276 molecule |
chr4_-_146859623 | 1.73 |
ENST00000379448.4
ENST00000513320.1 |
ZNF827
|
zinc finger protein 827 |
chr2_-_216257849 | 1.70 |
ENST00000456923.1
|
FN1
|
fibronectin 1 |
chr6_-_11779403 | 1.70 |
ENST00000414691.3
|
ADTRP
|
androgen-dependent TFPI-regulating protein |
chr16_+_82660635 | 1.68 |
ENST00000567445.1
ENST00000446376.2 |
CDH13
|
cadherin 13 |
chr11_-_65429891 | 1.64 |
ENST00000527874.1
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A |
chrX_-_30993201 | 1.62 |
ENST00000288422.2
ENST00000378932.2 |
TAB3
|
TGF-beta activated kinase 1/MAP3K7 binding protein 3 |
chr2_+_102953608 | 1.61 |
ENST00000311734.2
ENST00000409584.1 |
IL1RL1
|
interleukin 1 receptor-like 1 |
chr7_-_127671674 | 1.60 |
ENST00000478726.1
|
LRRC4
|
leucine rich repeat containing 4 |
chr4_-_74486109 | 1.58 |
ENST00000395777.2
|
RASSF6
|
Ras association (RalGDS/AF-6) domain family member 6 |
chr9_+_2159850 | 1.58 |
ENST00000416751.1
|
SMARCA2
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 |
chr6_+_149539767 | 1.56 |
ENST00000606202.1
ENST00000536230.1 ENST00000445901.1 |
TAB2
RP1-111D6.3
|
TGF-beta activated kinase 1/MAP3K7 binding protein 2 RP1-111D6.3 |
chr3_-_71294304 | 1.56 |
ENST00000498215.1
|
FOXP1
|
forkhead box P1 |
chr4_-_157892167 | 1.54 |
ENST00000541126.1
|
PDGFC
|
platelet derived growth factor C |
chr20_+_58179582 | 1.52 |
ENST00000371015.1
ENST00000395639.4 |
PHACTR3
|
phosphatase and actin regulator 3 |
chr3_+_193853927 | 1.52 |
ENST00000232424.3
|
HES1
|
hes family bHLH transcription factor 1 |
chr1_-_68698197 | 1.49 |
ENST00000370973.2
ENST00000370971.1 |
WLS
|
wntless Wnt ligand secretion mediator |
chrX_-_15619076 | 1.48 |
ENST00000252519.3
|
ACE2
|
angiotensin I converting enzyme 2 |
chr1_+_112938803 | 1.47 |
ENST00000271277.6
|
CTTNBP2NL
|
CTTNBP2 N-terminal like |
chr6_-_10412600 | 1.47 |
ENST00000379608.3
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
chr11_-_65430251 | 1.42 |
ENST00000534283.1
ENST00000527749.1 ENST00000533187.1 ENST00000525693.1 ENST00000534558.1 ENST00000532879.1 ENST00000532999.1 |
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A |
chr4_-_146859787 | 1.42 |
ENST00000508784.1
|
ZNF827
|
zinc finger protein 827 |
chr4_-_153303658 | 1.41 |
ENST00000296555.5
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
chr8_-_72268721 | 1.37 |
ENST00000419131.1
ENST00000388743.2 |
EYA1
|
eyes absent homolog 1 (Drosophila) |
chr20_-_50808236 | 1.36 |
ENST00000361387.2
|
ZFP64
|
ZFP64 zinc finger protein |
chr9_+_22646189 | 1.35 |
ENST00000436786.1
|
RP11-399D6.2
|
RP11-399D6.2 |
chr11_+_71903169 | 1.34 |
ENST00000393676.3
|
FOLR1
|
folate receptor 1 (adult) |
chr1_-_28384598 | 1.33 |
ENST00000373864.1
|
EYA3
|
eyes absent homolog 3 (Drosophila) |
chr5_-_133706695 | 1.32 |
ENST00000521755.1
ENST00000523054.1 ENST00000435240.2 ENST00000609654.1 ENST00000536186.1 ENST00000609383.1 |
CDKL3
|
cyclin-dependent kinase-like 3 |
chr1_+_150954493 | 1.31 |
ENST00000368947.4
|
ANXA9
|
annexin A9 |
chr13_-_46756351 | 1.31 |
ENST00000323076.2
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
chr4_+_26322185 | 1.30 |
ENST00000361572.6
|
RBPJ
|
recombination signal binding protein for immunoglobulin kappa J region |
chr3_+_57882061 | 1.29 |
ENST00000461354.1
ENST00000466255.1 |
SLMAP
|
sarcolemma associated protein |
chr3_+_177159695 | 1.29 |
ENST00000442937.1
|
LINC00578
|
long intergenic non-protein coding RNA 578 |
chr1_-_68698222 | 1.28 |
ENST00000370976.3
ENST00000354777.2 ENST00000262348.4 ENST00000540432.1 |
WLS
|
wntless Wnt ligand secretion mediator |
chr12_-_104443890 | 1.28 |
ENST00000547583.1
ENST00000360814.4 ENST00000546851.1 |
GLT8D2
|
glycosyltransferase 8 domain containing 2 |
chr4_-_157892498 | 1.26 |
ENST00000502773.1
|
PDGFC
|
platelet derived growth factor C |
chr12_-_80328905 | 1.24 |
ENST00000547330.1
|
PPP1R12A
|
protein phosphatase 1, regulatory subunit 12A |
chr1_+_111682058 | 1.23 |
ENST00000545121.1
|
CEPT1
|
choline/ethanolamine phosphotransferase 1 |
chr11_-_96076334 | 1.22 |
ENST00000524717.1
|
MAML2
|
mastermind-like 2 (Drosophila) |
chr6_+_36839616 | 1.21 |
ENST00000359359.2
ENST00000510325.2 |
C6orf89
|
chromosome 6 open reading frame 89 |
chr6_-_112081113 | 1.20 |
ENST00000517419.1
|
FYN
|
FYN oncogene related to SRC, FGR, YES |
chr17_-_7387524 | 1.19 |
ENST00000311403.4
|
ZBTB4
|
zinc finger and BTB domain containing 4 |
chr3_+_136649311 | 1.19 |
ENST00000469404.1
ENST00000467911.1 |
NCK1
|
NCK adaptor protein 1 |
chr6_-_11779014 | 1.19 |
ENST00000229583.5
|
ADTRP
|
androgen-dependent TFPI-regulating protein |
chr8_+_97597148 | 1.18 |
ENST00000521590.1
|
SDC2
|
syndecan 2 |
chr13_-_48669204 | 1.18 |
ENST00000417167.1
|
MED4
|
mediator complex subunit 4 |
chr16_+_21623958 | 1.17 |
ENST00000568826.1
|
METTL9
|
methyltransferase like 9 |
chr8_-_128231299 | 1.17 |
ENST00000500112.1
|
CCAT1
|
colon cancer associated transcript 1 (non-protein coding) |
chr4_+_124320665 | 1.15 |
ENST00000394339.2
|
SPRY1
|
sprouty homolog 1, antagonist of FGF signaling (Drosophila) |
chr1_-_110155671 | 1.14 |
ENST00000351050.3
|
GNAT2
|
guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2 |
chr18_-_21852143 | 1.14 |
ENST00000399443.3
|
OSBPL1A
|
oxysterol binding protein-like 1A |
chr13_-_48669232 | 1.09 |
ENST00000258648.2
ENST00000378586.1 |
MED4
|
mediator complex subunit 4 |
chr1_+_61330931 | 1.08 |
ENST00000371191.1
|
NFIA
|
nuclear factor I/A |
chr3_-_71632894 | 1.07 |
ENST00000493089.1
|
FOXP1
|
forkhead box P1 |
chr14_+_85994943 | 1.06 |
ENST00000553678.1
|
RP11-497E19.2
|
Uncharacterized protein |
chr1_-_152297679 | 1.06 |
ENST00000368799.1
|
FLG
|
filaggrin |
chr8_-_133637624 | 1.04 |
ENST00000522789.1
|
LRRC6
|
leucine rich repeat containing 6 |
chr6_+_21593972 | 1.03 |
ENST00000244745.1
ENST00000543472.1 |
SOX4
|
SRY (sex determining region Y)-box 4 |
chr4_-_157892055 | 1.02 |
ENST00000422544.2
|
PDGFC
|
platelet derived growth factor C |
chr17_+_4846101 | 1.02 |
ENST00000576965.1
|
RNF167
|
ring finger protein 167 |
chr20_+_52105495 | 1.01 |
ENST00000439873.2
|
AL354993.1
|
Cell growth-inhibiting protein 7; HCG1784586; Uncharacterized protein |
chr6_+_158733692 | 1.00 |
ENST00000367094.2
ENST00000367097.3 |
TULP4
|
tubby like protein 4 |
chr18_+_43914159 | 1.00 |
ENST00000588679.1
ENST00000269439.7 ENST00000543885.1 |
RNF165
|
ring finger protein 165 |
chr12_+_122459757 | 0.99 |
ENST00000261822.4
|
BCL7A
|
B-cell CLL/lymphoma 7A |
chr6_+_43149903 | 0.98 |
ENST00000252050.4
ENST00000354495.3 ENST00000372647.2 |
CUL9
|
cullin 9 |
chr4_-_153456153 | 0.97 |
ENST00000603548.1
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
chr9_+_706842 | 0.97 |
ENST00000382293.3
|
KANK1
|
KN motif and ankyrin repeat domains 1 |
chr3_+_57881966 | 0.96 |
ENST00000495364.1
|
SLMAP
|
sarcolemma associated protein |
chr9_-_70490107 | 0.95 |
ENST00000377395.4
ENST00000429800.2 ENST00000430059.2 ENST00000377384.1 ENST00000382405.3 |
CBWD5
|
COBW domain containing 5 |
chr9_+_124062071 | 0.95 |
ENST00000373818.4
|
GSN
|
gelsolin |
chr5_+_43602750 | 0.95 |
ENST00000505678.2
ENST00000512422.1 ENST00000264663.5 |
NNT
|
nicotinamide nucleotide transhydrogenase |
chr1_+_209941942 | 0.94 |
ENST00000487271.1
ENST00000477431.1 |
TRAF3IP3
|
TRAF3 interacting protein 3 |
chr7_+_123469037 | 0.94 |
ENST00000489978.1
|
HYAL4
|
hyaluronoglucosaminidase 4 |
chr1_+_2066387 | 0.93 |
ENST00000497183.1
|
PRKCZ
|
protein kinase C, zeta |
chr5_+_122847908 | 0.93 |
ENST00000511130.2
ENST00000512718.3 |
CSNK1G3
|
casein kinase 1, gamma 3 |
chrX_-_24665208 | 0.93 |
ENST00000356768.4
|
PCYT1B
|
phosphate cytidylyltransferase 1, choline, beta |
chr10_-_24911746 | 0.92 |
ENST00000320481.6
|
ARHGAP21
|
Rho GTPase activating protein 21 |
chr1_+_40627038 | 0.90 |
ENST00000372771.4
|
RLF
|
rearranged L-myc fusion |
chrX_+_133507389 | 0.90 |
ENST00000370800.4
|
PHF6
|
PHD finger protein 6 |
chr17_+_55055466 | 0.89 |
ENST00000262288.3
ENST00000572710.1 ENST00000575395.1 |
SCPEP1
|
serine carboxypeptidase 1 |
chr1_+_230193521 | 0.89 |
ENST00000543760.1
|
GALNT2
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2) |
chr6_+_15246501 | 0.89 |
ENST00000341776.2
|
JARID2
|
jumonji, AT rich interactive domain 2 |
chrX_-_117119243 | 0.88 |
ENST00000539496.1
ENST00000469946.1 |
KLHL13
|
kelch-like family member 13 |
chr19_+_11200038 | 0.87 |
ENST00000558518.1
ENST00000557933.1 ENST00000455727.2 ENST00000535915.1 ENST00000545707.1 ENST00000558013.1 |
LDLR
|
low density lipoprotein receptor |
chr17_+_7387919 | 0.87 |
ENST00000572844.1
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa |
chr21_+_39628780 | 0.86 |
ENST00000417042.1
|
KCNJ15
|
potassium inwardly-rectifying channel, subfamily J, member 15 |
chr4_+_74347400 | 0.86 |
ENST00000226355.3
|
AFM
|
afamin |
chr10_+_121578211 | 0.85 |
ENST00000369080.3
|
INPP5F
|
inositol polyphosphate-5-phosphatase F |
chr2_-_33824336 | 0.85 |
ENST00000431950.1
ENST00000403368.1 ENST00000441530.2 |
FAM98A
|
family with sequence similarity 98, member A |
chr14_+_35591509 | 0.85 |
ENST00000604073.1
|
KIAA0391
|
KIAA0391 |
chrX_-_15683147 | 0.85 |
ENST00000380342.3
|
TMEM27
|
transmembrane protein 27 |
chr1_+_9711781 | 0.84 |
ENST00000536656.1
ENST00000377346.4 |
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
chr5_+_173316341 | 0.84 |
ENST00000520867.1
ENST00000334035.5 |
CPEB4
|
cytoplasmic polyadenylation element binding protein 4 |
chr6_-_143266297 | 0.84 |
ENST00000367603.2
|
HIVEP2
|
human immunodeficiency virus type I enhancer binding protein 2 |
chr7_-_64451414 | 0.84 |
ENST00000282869.6
|
ZNF117
|
zinc finger protein 117 |
chr15_-_83837983 | 0.83 |
ENST00000562702.1
|
HDGFRP3
|
Hepatoma-derived growth factor-related protein 3 |
chr4_-_186733363 | 0.82 |
ENST00000393523.2
ENST00000393528.3 ENST00000449407.2 |
SORBS2
|
sorbin and SH3 domain containing 2 |
chr11_-_33891362 | 0.82 |
ENST00000395833.3
|
LMO2
|
LIM domain only 2 (rhombotin-like 1) |
chr4_-_153274078 | 0.81 |
ENST00000263981.5
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase |
chr8_-_101964231 | 0.81 |
ENST00000521309.1
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta |
chr1_+_174933899 | 0.80 |
ENST00000367688.3
|
RABGAP1L
|
RAB GTPase activating protein 1-like |
chr1_-_147955419 | 0.79 |
ENST00000539781.1
|
PPIAL4A
|
peptidylprolyl isomerase A (cyclophilin A)-like 4A |
chr13_+_20532848 | 0.78 |
ENST00000382874.2
|
ZMYM2
|
zinc finger, MYM-type 2 |
chr2_-_85637459 | 0.77 |
ENST00000409921.1
|
CAPG
|
capping protein (actin filament), gelsolin-like |
chr5_-_124084493 | 0.77 |
ENST00000509799.1
|
ZNF608
|
zinc finger protein 608 |
chr8_+_9046503 | 0.76 |
ENST00000512942.2
|
RP11-10A14.5
|
RP11-10A14.5 |
chr4_-_48014931 | 0.74 |
ENST00000420489.2
ENST00000504722.1 |
CNGA1
|
cyclic nucleotide gated channel alpha 1 |
chr15_+_40731920 | 0.74 |
ENST00000561234.1
|
BAHD1
|
bromo adjacent homology domain containing 1 |
chr2_-_214015111 | 0.74 |
ENST00000433134.1
|
IKZF2
|
IKAROS family zinc finger 2 (Helios) |
chr13_+_76413852 | 0.72 |
ENST00000533809.2
|
LMO7
|
LIM domain 7 |
chr2_+_187350883 | 0.72 |
ENST00000337859.6
|
ZC3H15
|
zinc finger CCCH-type containing 15 |
chr3_+_57882024 | 0.72 |
ENST00000494088.1
|
SLMAP
|
sarcolemma associated protein |
chr12_-_4488872 | 0.71 |
ENST00000237837.1
|
FGF23
|
fibroblast growth factor 23 |
chr8_+_104831554 | 0.71 |
ENST00000408894.2
|
RIMS2
|
regulating synaptic membrane exocytosis 2 |
chr19_+_10197463 | 0.71 |
ENST00000590378.1
ENST00000397881.3 |
C19orf66
|
chromosome 19 open reading frame 66 |
chr12_-_80328949 | 0.71 |
ENST00000450142.2
|
PPP1R12A
|
protein phosphatase 1, regulatory subunit 12A |
chr2_-_127963343 | 0.71 |
ENST00000335247.7
|
CYP27C1
|
cytochrome P450, family 27, subfamily C, polypeptide 1 |
chr10_-_119805558 | 0.70 |
ENST00000369199.3
|
RAB11FIP2
|
RAB11 family interacting protein 2 (class I) |
chr1_+_104198377 | 0.70 |
ENST00000370083.4
|
AMY1A
|
amylase, alpha 1A (salivary) |
chr20_+_44509857 | 0.70 |
ENST00000372523.1
ENST00000372520.1 |
ZSWIM1
|
zinc finger, SWIM-type containing 1 |
chr13_+_20532900 | 0.69 |
ENST00000382871.2
|
ZMYM2
|
zinc finger, MYM-type 2 |
chr3_+_177159744 | 0.69 |
ENST00000439009.1
|
LINC00578
|
long intergenic non-protein coding RNA 578 |
chr14_+_91709279 | 0.69 |
ENST00000554096.1
|
CTD-2547L24.3
|
HCG1816139; Uncharacterized protein |
chr1_-_11118896 | 0.69 |
ENST00000465788.1
|
SRM
|
spermidine synthase |
chr10_+_13628933 | 0.68 |
ENST00000417658.1
ENST00000320054.4 |
PRPF18
|
pre-mRNA processing factor 18 |
chr1_+_28995258 | 0.67 |
ENST00000361872.4
ENST00000294409.2 |
GMEB1
|
glucocorticoid modulatory element binding protein 1 |
chr7_+_107224364 | 0.67 |
ENST00000491150.1
|
BCAP29
|
B-cell receptor-associated protein 29 |
chr10_+_112679301 | 0.66 |
ENST00000265277.5
ENST00000369452.4 |
SHOC2
|
soc-2 suppressor of clear homolog (C. elegans) |
chr10_-_61495760 | 0.65 |
ENST00000395347.1
|
SLC16A9
|
solute carrier family 16, member 9 |
chr17_+_28443799 | 0.65 |
ENST00000584423.1
ENST00000247026.5 |
NSRP1
|
nuclear speckle splicing regulatory protein 1 |
chrX_+_100663243 | 0.65 |
ENST00000316594.5
|
HNRNPH2
|
heterogeneous nuclear ribonucleoprotein H2 (H') |
chr6_+_106534192 | 0.64 |
ENST00000369091.2
ENST00000369096.4 |
PRDM1
|
PR domain containing 1, with ZNF domain |
chr5_+_34685805 | 0.64 |
ENST00000508315.1
|
RAI14
|
retinoic acid induced 14 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 4.0 | GO:1904237 | regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
1.0 | 3.1 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
0.9 | 2.7 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
0.7 | 2.8 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.7 | 2.0 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
0.6 | 2.5 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.6 | 3.2 | GO:2000639 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.6 | 3.6 | GO:0032571 | response to vitamin K(GO:0032571) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) bone regeneration(GO:1990523) |
0.5 | 4.0 | GO:1901189 | positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.5 | 2.0 | GO:0009956 | radial pattern formation(GO:0009956) |
0.5 | 2.4 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.4 | 1.3 | GO:0003147 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
0.4 | 2.6 | GO:0072619 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.4 | 6.1 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.4 | 1.2 | GO:1903676 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
0.4 | 3.0 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
0.4 | 2.1 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.3 | 7.9 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.3 | 1.0 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.3 | 2.1 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.3 | 1.5 | GO:0003051 | angiotensin-mediated drinking behavior(GO:0003051) |
0.3 | 1.5 | GO:0021557 | optic cup structural organization(GO:0003409) oculomotor nerve development(GO:0021557) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
0.3 | 1.1 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
0.3 | 4.9 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.3 | 6.8 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.3 | 0.3 | GO:2000257 | regulation of protein activation cascade(GO:2000257) |
0.2 | 2.4 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.2 | 1.6 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.2 | 0.7 | GO:0071030 | nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
0.2 | 2.7 | GO:0021759 | globus pallidus development(GO:0021759) |
0.2 | 0.9 | GO:1903979 | negative regulation of microglial cell activation(GO:1903979) |
0.2 | 1.4 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.2 | 2.0 | GO:0033183 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
0.2 | 6.7 | GO:0002076 | osteoblast development(GO:0002076) |
0.2 | 13.1 | GO:0032731 | positive regulation of interleukin-1 beta production(GO:0032731) |
0.2 | 0.9 | GO:1903906 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.2 | 3.6 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.2 | 3.9 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.2 | 3.6 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.2 | 2.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.2 | 0.7 | GO:0042369 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) vitamin D catabolic process(GO:0042369) |
0.2 | 0.5 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.2 | 1.1 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.2 | 1.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.2 | 1.2 | GO:0008218 | bioluminescence(GO:0008218) |
0.2 | 0.8 | GO:0060374 | mast cell differentiation(GO:0060374) |
0.2 | 0.6 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.2 | 2.0 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.2 | 1.6 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.2 | 3.3 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.9 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.1 | 1.7 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.1 | 0.4 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.1 | 3.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 1.2 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.1 | 0.4 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
0.1 | 0.9 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 2.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.5 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.1 | 0.5 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.9 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.1 | 2.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.1 | 2.9 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 1.7 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 2.4 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 1.0 | GO:0021564 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) vagus nerve development(GO:0021564) |
0.1 | 0.6 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.1 | 0.7 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 1.1 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.1 | 0.8 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 2.1 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 1.2 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) negative regulation of dendritic spine maintenance(GO:1902951) |
0.1 | 0.4 | GO:0061015 | snRNA import into nucleus(GO:0061015) |
0.1 | 0.5 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 1.0 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.1 | 0.6 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.5 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.1 | 0.5 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.1 | 1.0 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 1.7 | GO:0072189 | ureter development(GO:0072189) |
0.1 | 0.6 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 1.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.4 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.1 | 0.7 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.2 | GO:0051834 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.1 | 0.5 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.1 | 0.9 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.4 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 0.7 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.1 | 0.8 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 3.7 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.1 | 0.2 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.1 | 0.2 | GO:1905064 | response to mycophenolic acid(GO:0071505) cellular response to mycophenolic acid(GO:0071506) metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) negative regulation of vascular smooth muscle cell differentiation(GO:1905064) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
0.1 | 0.9 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.0 | 8.6 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.2 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
0.0 | 0.2 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) swimming behavior(GO:0036269) |
0.0 | 0.6 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.4 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.0 | 2.3 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.6 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 0.9 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.0 | 3.2 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) |
0.0 | 1.6 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.0 | 0.1 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.0 | 0.3 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 2.8 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.7 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.0 | 0.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.4 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.0 | 0.8 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.0 | 0.5 | GO:0032782 | bile acid secretion(GO:0032782) |
0.0 | 0.3 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
0.0 | 0.7 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.7 | GO:0007586 | digestion(GO:0007586) |
0.0 | 0.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.0 | 0.7 | GO:0021889 | olfactory bulb interneuron differentiation(GO:0021889) |
0.0 | 0.1 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.0 | 0.2 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.0 | 3.0 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.6 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.4 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.0 | 0.3 | GO:0031344 | regulation of cell projection organization(GO:0031344) |
0.0 | 1.9 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 1.0 | GO:0060384 | innervation(GO:0060384) |
0.0 | 1.3 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.0 | 0.2 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.0 | 0.2 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) negative regulation of podosome assembly(GO:0071802) |
0.0 | 0.8 | GO:1901880 | negative regulation of protein depolymerization(GO:1901880) |
0.0 | 0.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.1 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.0 | 0.1 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.0 | 1.0 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.3 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.0 | 0.4 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.4 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.0 | 1.1 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.0 | 0.1 | GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) mineralocorticoid receptor signaling pathway(GO:0031959) |
0.0 | 1.1 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.7 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.0 | 0.2 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.0 | 3.4 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.0 | 0.1 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.0 | 0.5 | GO:0007617 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
0.0 | 1.5 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
0.0 | 1.8 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.9 | GO:0051180 | vitamin transport(GO:0051180) |
0.0 | 0.3 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.2 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.0 | 0.6 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.1 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.1 | GO:1901374 | acetate ester transport(GO:1901374) |
0.0 | 0.3 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.2 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.0 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.0 | 0.4 | GO:0002793 | positive regulation of peptide secretion(GO:0002793) positive regulation of peptide hormone secretion(GO:0090277) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 3.1 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
0.7 | 2.2 | GO:0005595 | collagen type XII trimer(GO:0005595) |
0.5 | 3.2 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.4 | 4.0 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.4 | 1.1 | GO:0036457 | keratohyalin granule(GO:0036457) |
0.3 | 0.9 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
0.3 | 4.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 2.3 | GO:0070847 | core mediator complex(GO:0070847) |
0.3 | 2.0 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.2 | 3.6 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 0.7 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
0.2 | 0.6 | GO:0031213 | RSF complex(GO:0031213) |
0.1 | 1.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 2.7 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 2.0 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 2.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 1.6 | GO:0045179 | apical cortex(GO:0045179) |
0.1 | 0.6 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 1.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 1.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 4.1 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 0.9 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 1.8 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 1.6 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 1.3 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 1.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 2.6 | GO:0032590 | dendrite membrane(GO:0032590) |
0.0 | 3.0 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.5 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 1.3 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.5 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 5.8 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.4 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 0.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 3.0 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 1.0 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.2 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.0 | 3.7 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.4 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.2 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.0 | 0.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 0.3 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 0.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 3.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 2.2 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 17.7 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.0 | 0.9 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.3 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.0 | 0.8 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.3 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.9 | GO:0097228 | sperm principal piece(GO:0097228) |
0.0 | 0.2 | GO:0016013 | syntrophin complex(GO:0016013) |
0.0 | 0.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.5 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 2.2 | GO:0016363 | nuclear matrix(GO:0016363) |
0.0 | 0.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 1.5 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 2.8 | GO:0043197 | dendritic spine(GO:0043197) |
0.0 | 0.1 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.0 | 0.9 | GO:0042175 | endoplasmic reticulum membrane(GO:0005789) nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.0 | 1.6 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 1.4 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
0.0 | 2.3 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.5 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 4.6 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 0.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.0 | 1.9 | GO:0055037 | recycling endosome(GO:0055037) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 6.1 | GO:0055100 | adiponectin binding(GO:0055100) |
0.9 | 2.7 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.6 | 2.8 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.5 | 1.6 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.5 | 4.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.5 | 1.4 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.4 | 3.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 1.8 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.3 | 1.3 | GO:0061714 | folic acid receptor activity(GO:0061714) |
0.3 | 1.2 | GO:0004307 | diacylglycerol cholinephosphotransferase activity(GO:0004142) ethanolaminephosphotransferase activity(GO:0004307) |
0.3 | 2.4 | GO:0045118 | azole transporter activity(GO:0045118) |
0.3 | 2.3 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.3 | 3.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.2 | 1.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 2.1 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 0.7 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.2 | 0.9 | GO:0008431 | vitamin E binding(GO:0008431) |
0.2 | 8.2 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 2.2 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.2 | 4.0 | GO:0000150 | recombinase activity(GO:0000150) |
0.2 | 0.8 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
0.2 | 0.9 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.2 | 1.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.2 | 5.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.2 | 0.5 | GO:0070538 | oleic acid binding(GO:0070538) |
0.1 | 0.7 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 2.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 0.7 | GO:0005502 | 11-cis retinal binding(GO:0005502) all-trans retinal binding(GO:0005503) |
0.1 | 0.7 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.1 | 0.6 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.7 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.4 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.1 | 1.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.6 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
0.1 | 2.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 2.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 2.0 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.1 | 0.9 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.1 | 1.1 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 3.6 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 2.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 3.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.4 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.1 | 0.9 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 3.9 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 1.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 1.6 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.9 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 1.6 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.4 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.9 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.5 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 3.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.9 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 0.6 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.1 | 2.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 1.1 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 0.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.3 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 0.5 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 2.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.9 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.2 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.0 | 0.7 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.2 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
0.0 | 2.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 2.6 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 7.0 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 11.8 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.0 | 1.3 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.0 | 2.0 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.5 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 11.6 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 1.0 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 2.0 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.9 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.1 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) secondary active organic cation transmembrane transporter activity(GO:0008513) acetate ester transmembrane transporter activity(GO:1901375) |
0.0 | 0.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 1.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 2.6 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.9 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.0 | 1.4 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 1.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 1.1 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.0 | 0.9 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 1.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.2 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.0 | 1.8 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.3 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 2.9 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.6 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.1 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.0 | 0.3 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.1 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.0 | 0.2 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.0 | 1.1 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.0 | 0.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.4 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.1 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.0 | 0.1 | GO:0030911 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) TPR domain binding(GO:0030911) |
0.0 | 0.6 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.2 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.0 | 0.5 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.1 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.0 | 1.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.3 | GO:0016891 | endoribonuclease activity, producing 5'-phosphomonoesters(GO:0016891) |
0.0 | 0.1 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 2.2 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.4 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.3 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.4 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 6.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 4.8 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 5.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.1 | 3.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 5.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 3.8 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 6.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 4.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 2.3 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.5 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 2.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 3.7 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.9 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 2.9 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.0 | 1.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 1.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 1.3 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 3.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 1.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.7 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.7 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 0.9 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.7 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 1.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.5 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.3 | 5.3 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 3.1 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.2 | 3.2 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.2 | 3.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 7.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 4.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 4.3 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 2.7 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 6.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 1.0 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 1.7 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 2.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 5.3 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 2.7 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 1.8 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 0.7 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 4.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 2.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 2.3 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.0 | 0.7 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 1.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 1.6 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.7 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.9 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 3.9 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 1.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 1.2 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 2.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 1.5 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 3.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 11.2 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.9 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.4 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.5 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 1.1 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 0.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.0 | 0.5 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 1.7 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.4 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.0 | 0.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.3 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |